The present invention is directed to a process for the diastereoselective synthesis of phosphorus compounds, particularly pronucleotides (nucleotide prodrugs). Pronucleotides represent a promising alternative to improve the biological activity of nucleoside analogs in antiviral and cancer chemotherapy.
Further Information: PDF
TuTech Innovation GmbH (TuTech)
Phone: +49 (0)40/76629-6542
Contact
Astrid Stichnoth, Dr. Stefanie Klingelhöfer, Karl-Heinz Rehfeldt, Ingo Siebert
